ACCESSION: MSBNK-SMB_Measured-HSA014P0295001
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL24-neg_2728': {'bp': 98389.0, 'sum': 250244.0}, 'EL23-neg_2748': {'bp': 95967.0, 'sum': 261248.0}, 'EL05-neg_2742': {'bp': 94668.0, 'sum': 247101.0}, 'EL16-neg_2734': {'bp': 91736.0, 'sum': 235953.0}, 'EL15-neg_2751': {'bp': 87254.0, 'sum': 246214.0}, 'EL09-neg_2741': {'bp': 80746.0, 'sum': 230099.0}, 'EL01-neg_2741': {'bp': 78298.0, 'sum': 218295.0}, 'EL06-neg_2741': {'bp': 78295.0, 'sum': 210978.0}, 'EL17-neg_2736': {'bp': 77333.0, 'sum': 210146.0}, 'EL18-neg_2738': {'bp': 77043.0, 'sum': 214465.0}, 'EL02-neg_2768': {'bp': 75873.0, 'sum': 217567.0}, 'EL03-neg_2738': {'bp': 75567.0, 'sum': 191298.0}, 'EL04-neg_2724': {'bp': 75230.0, 'sum': 197466.0}, 'EL07-neg_2730': {'bp': 72229.0, 'sum': 206550.0}, 'EL20-neg_2753': {'bp': 72156.0, 'sum': 200331.0}, 'EL12-neg_2752': {'bp': 69758.0, 'sum': 182293.0}, 'EL11-neg_2736': {'bp': 67697.0, 'sum': 170256.0}, 'EL19-neg_2747': {'bp': 66762.0, 'sum': 200850.0}, 'EL13-neg_2743': {'bp': 64900.0, 'sum': 185700.0}, 'EL21-neg_2732': {'bp': 64367.0, 'sum': 175163.0}, 'EL22-neg_2746': {'bp': 61171.0, 'sum': 199405.0}, 'EL14-neg_2743': {'bp': 59557.0, 'sum': 166565.0}, 'EL10-neg_2748': {'bp': 59147.0, 'sum': 174546.0}, 'EL08-neg_2730': {'bp': 58869.0, 'sum': 187563.0}}
COMMENT: RETENTION_TIME_STDEV 0.011
COMMENT: PRECURSOR_M/Z_RAW 295.139765
COMMENT: PRECURSOR_M/Z_STDEV 0.000115
COMMENT: PRECURSOR_IN_MS1 mz 295.139728; int 20.843; delta(ppm) 0.704971
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.879; C13H20N4O4; [M-H]1; delta(ppm) -4.879333
COMMENT: PROPOSED_MF SevenGoldenRules 0.365; C12H24O8; [M-H]1; delta(ppm) -0.364684
COMMENT: PROPOSED_MF SevenGoldenRules 3.799; C16H26OP2; [M-H]1; delta(ppm) 3.798789
COMMENT: PROPOSED_MF MS-FINDER 3.114; C12H24O8; [M-H]-; delta(ppm) -0.363589
COMMENT: PROPOSED_MF MS-FINDER 2.679; C13H20N4O4; [M-H]-; delta(ppm) -4.895026
COMMENT: PROPOSED_MF MS-FINDER 2.295; C7H21N8O3P; [M-H]-; delta(ppm) -1.393112
COMMENT: PROPOSED_MF MS-FINDER 2.049; C13H28O3S2; [M-H]-; delta(ppm) -3.308006
COMMENT: PROPOSED_MF MS-FINDER 2.029; C9H16N10O2; [M-H]-; delta(ppm) 4.203462
COMMENT: PROPOSED_MF SIRIUS5_Sirius 11.851; C12H24O8; [M-H]-; delta(ppm) -0.363589
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.562; C13H20N4O4; [M-H]-; delta(ppm) -4.895026
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.040; C16H24O3S; [M-H]-; delta(ppm) 8.114190
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.065; C14H16N8; [M-H]-; delta(ppm) -9.426421
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.996; C12H24O8; [M-H]-; delta(ppm) -0.363589
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.004; C13H20N4O4; [M-H]-; delta(ppm) -4.895026
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.863; C12H24O8; [M-H]-; delta(ppm) -0.363589
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.536; C13H20N4O4; [M-H]-; delta(ppm) -4.895026
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.014; C16H24O3S; [M-H]-; delta(ppm) 8.114190
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.994; C10H22N3O7; [M-H]-; delta(ppm) 4.185675
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.511; C13H25FO4S; [M-H]-; delta(ppm) 4.242572
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.132; C11H19F3N4O2; [M-H]-; delta(ppm) 3.390108
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.020; C13H28O3S2; [M-H]-; delta(ppm) -3.308006
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.843; C11H28O5Si2; [M-H]-; delta(ppm) -178076.971208
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.658; C15H22NO5; [M-H]-; delta(ppm) -9.444208
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.122; C10H21FN4O5; [M-H]-; delta(ppm) -8.766542
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.988; C12H24O8; [M-H]-; delta(ppm) -0.363589
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.011; C13H20N4O4; [M-H]-; delta(ppm) -4.895026
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C13H25FO4S; [M-H]-; delta(ppm) 4.242572
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.486; QKTRZPZQRUBLRL-UHFFFAOYSA-N; [M-H]-; OC1C(NC2CCOCC2)C3OC(OC3)C1N4N=CN=C4
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.444; WVCGMCXXESDLGM-UHFFFAOYSA-N; [M-H]-; O=C(NCCC)NC1C(O)C(N2C=NC=C2)C3OCC1O3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.415; GOXIFAJQXIUTPO-UHFFFAOYSA-N; [M-H]-; O=C(NCCC)NC1C(O)C(N2N=CC=C2)C3OCC1O3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.384; LNDPJNJZMAGULR-UHFFFAOYSA-N; [M-H]-; O=C(NC(C)C)NC1C(O)C(N2C=NC=C2)C3OCC1O3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.359; OAAASGFKFHJSAK-UHFFFAOYSA-N; [M-H]-; O=C(NC(C)C)NC1C(O)C(N2N=CC=C2)C3OCC1O3
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.885; COAMNWKAJPDNHU-ADMGZDJQNA-N; [M-H]-; UNPD86121
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.113; KWBJCKCMGCIRBF-UHFFFAOYSA-N; [M-H]-; 3-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-2-[(1-methylpiperidin-4-yl)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.085; CLEJSZMKLNKPMH-UHFFFAOYSA-N; [M-H]-; N-{2,8-dioxo-1,7,11-triazatricyclo[7.4.0.0?,?]tridecan-5-yl}-2-methoxyacetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.079; QKOSMVWTCUCGLJ-UHFFFAOYSA-N; [M-H]-; 3-methyl-8-(morpholine-4-carbonyl)-octahydro-1H-[1,4]diazino[1,2-a]pyrazine-1,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.064; QKTRZPZQRUBLRL-UHFFFAOYSA-N; [M-H]-; 2-[(oxan-4-yl)amino]-4-(1H-1,2,4-triazol-1-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.057; GOXIFAJQXIUTPO-UHFFFAOYSA-N; [M-H]-; 1-[3-hydroxy-4-(1H-pyrazol-1-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]-3-propylurea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.057; OAAASGFKFHJSAK-UHFFFAOYSA-N; [M-H]-; 1-[3-hydroxy-4-(1H-pyrazol-1-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.051; LNDPJNJZMAGULR-UHFFFAOYSA-N; [M-H]-; 1-[3-hydroxy-4-(1H-imidazol-1-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.051; WVCGMCXXESDLGM-UHFFFAOYSA-N; [M-H]-; 1-[3-hydroxy-4-(1H-imidazol-1-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]-3-propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; CLEJSZMKLNKPMH-UHFFFAOYSA-N; [M-H]-; N-{2,8-dioxo-1,7,11-triazatricyclo[7.4.0.0?,?]tridecan-5-yl}-2-methoxyacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; COAMNWKAJPDNHU-ADMGZDJQNA-N; [M-H]-; UNPD86121
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.665; KWBJCKCMGCIRBF-UHFFFAOYSA-N; [M-H]-; 3-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-2-[(1-methylpiperidin-4-yl)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.567; GOXIFAJQXIUTPO-UHFFFAOYSA-N; [M-H]-; 1-[3-hydroxy-4-(1H-pyrazol-1-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]-3-propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.567; LNDPJNJZMAGULR-UHFFFAOYSA-N; [M-H]-; 1-[3-hydroxy-4-(1H-imidazol-1-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.567; OAAASGFKFHJSAK-UHFFFAOYSA-N; [M-H]-; 1-[3-hydroxy-4-(1H-pyrazol-1-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.567; QKTRZPZQRUBLRL-UHFFFAOYSA-N; [M-H]-; 2-[(oxan-4-yl)amino]-4-(1H-1,2,4-triazol-1-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.567; WVCGMCXXESDLGM-UHFFFAOYSA-N; [M-H]-; 1-[3-hydroxy-4-(1H-imidazol-1-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]-3-propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; QKOSMVWTCUCGLJ-UHFFFAOYSA-N; [M-H]-; 3-methyl-8-(morpholine-4-carbonyl)-octahydro-1H-[1,4]diazino[1,2-a]pyrazine-1,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; YBAQBMKRLVJMKO-UHFFFAOYSA-N; [M-H]-; 1-(2-hydroxyethyl)-3-[2-(2-hydroxyethylcarbamoylamino)-3-methylphenyl]urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; SFMQXOOIHUKDLZ-UHFFFAOYSA-N; [M-H]-; 1-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]triazole-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.971; DTZZLOACXJNFIL-UHFFFAOYSA-N; [M-H]-; 7-(2,3-dihydroxypropyl)-1-methyl-3-(2-methylpropyl)purine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.744; UVKPCTJTHWZPKV-UHFFFAOYSA-N; [M-H]-; 7-(dimethoxymethyl)-1-methyl-3-(2-methylpropyl)purine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.729; ZJBOLBRXIQZJSF-VEDVMXKPSA-N; [M-H]-; 1-[(5R)-4,5-dihydroxyhexyl]-3,7-dimethylpurine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; PWJDQGYCPYBAEA-LUAWRHEFSA-N; [M-H]-; (Z)-2-(dipropylamino)-3-(5-nitrofuran-2-yl)prop-2-enehydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; HDSDGRXOONRLIE-VGOFMYFVSA-N; [M-H]-; 2-[di(propan-2-yl)amino]-N-[(E)-(5-nitrofuran-2-yl)methylideneamino]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; MEIXGBZODIXQNM-VIFPVBQESA-N; [M-H]-; 1-[[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]methyl]triazole-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; VREJDCMJBHJZIE-UHFFFAOYSA-N; [M-H]-; 1-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]triazole-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; PIQSVWCNBMSCSD-UHFFFAOYSA-N; [M-H]-; 2-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]triazole-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -123.173; SXGGZTBEWZFLBZ; [M-H]-; 2-[2-[2-[2-[2-(2-Hydroxyethyloxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanoic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -141.533; POEQOUHHEZELIV; [M-H]-; [3-hydroxy-2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propyl] acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.417; COAMNWKAJPDNHU; [M-H]-; (1S,3S,4R,5R)-1-[(2R,3S,5R)-3,5,6-trihydroxy-2-methyloxan-3-yl]hexane-1,3,4,5-tetrol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.061; SXGGZTBEWZFLBZ; [M-H]-; 2-[2-[2-[2-[2-(2-Hydroxyethyloxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanoic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -63.164; SXGGZTBEWZFLBZ; [M-H]-; 2-[2-[2-[2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -152.806; POEQOUHHEZELIV; [M-H]-; 2-[[3-(Acetyloxy)-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)-1,3-propanediol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -273.247; COAMNWKAJPDNHU; [M-H]-; Caryophyllose
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -297.698; YAQKVHDUVGFABU; [M-H]-; 2,2'-((4,6-Bis(allyloxy)-1,3,5-triazin-2-yl)imino)bisethanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -297.800; GBSPLYVCKRQDRS; [M-H]-; 4,4'-(1-Methyl-1,2-ethanediyl)bis(1-methyl-2,6-piperazinedione)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -361.515; VREJDCMJBHJZIE; [M-H]-; 1-{1-[(tert-butoxy)carbonyl]piperidin-3-yl}-1H-1,2,3-triazole-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -377.891; HDSDGRXOONRLIE; [M-H]-; 2-Furaldehyde, 5-nitro-, (diisopropylaminoacetyl)hydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -385.914; UVKPCTJTHWZPKV; [M-H]-; 1H-Purine-2,6-dione, 3,7-dihydro-7-(dimethoxymethyl)-1-methyl-3-(2-methylpropyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -399.081; YBAQBMKRLVJMKO; [M-H]-; Toluene, 2,3-bis(3-(2-hydroxyethyl)ureido)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -403.470; FDKDAXNUSYFTNE; [M-H]-; N-[[5-[(2S)-1-(2-methoxyethyl)-5-oxopyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl]methyl]propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.374; SXGGZTBEWZFLBZ; [M-H]-; 2-[2-[2-[2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]acetate
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C12H23O8; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 4.685
MS$FOCUSED_ION: PRECURSOR_M/Z 295.139734
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0002-5490000000-2d9c709d9858ee737608
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  59.0124691 264.0464 59.012445 0.8981 29.26 0.7522 24 ?
  61.0281150 149.2914 61.028091 1.0159 17.40 0.7905 23 ?
  72.9917047 226.5273 72.991688 0.7124 25.05 0.7174 24 ?
  75.0071876 45.7393 75.007172 1.1999 12.99 0.4623 21 ?
  90.9319789 47.7481 90.931980 1.3747 13.67 -0.0682 23 ?
  101.0229712 232.0192 101.022985 0.8711 29.27 0.6826 24 ?
  105.0543325 167.4514 105.054353 0.8472 26.52 0.7687 24 ?
  129.8777681 44.4982 129.877836 0.9855 14.17 -0.3540 22 ?
  135.0299003 115.9560 135.029980 1.1257 46.45 -0.5000 21 f{C4H7O5}/0.02ppm,p-C8H16O3
  295.1396733 999.0000 295.139918 0.5557 0.00 1.0000 24 f{C12H23O8}/-0.57ppm,p
  296.1433391 125.6181 296.143587 1.1920 24.69 0.3799 17 ?
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  59.012469 264.05 264
  61.028115 149.29 149
  72.991705 226.53 226
  75.007188 45.74 45
  90.931979 47.75 47
  101.022971 232.02 232
  105.054333 167.45 167
  129.877768 44.50 44
  135.029900 115.96 115
  295.139673 999.00 999
  296.143339 125.62 125
//
